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Abstract
Rare copy number variations have been linked to an important source of mutation in many psychopathological traits
and neurodevelopmental disorders. In this study, we describe a Taiwanese girl with mental retardation and mild
macrocephaly who underwent a childhood psychological evaluation for several years ﬁrst. When she was 5 years old, she
came to our hospital for further diagnosis. We conducted molecular cytogenetic tests and conﬁrmed she actually has
Sotos syndrome. We compared our case with two others with very similar deletion regions, but their phenotypes were
heterogeneous. Sotos syndrome is very rare in Taiwan, and it is suggested that genetic analysis should be considered
early if symptoms of this case are observed.
Keywords: Microdeletion, Psychological developmental delay, Sotos syndrome

1. Introduction

C

opy number variations (CNVs) are polymorphisms in the number of copies of chromosomal microdeletions and microduplications
(genomic rearrangements). They range from 1 kb to
several Mb and have been reported to be causal
suspects in various developmental disorders. CNVs
may change the dosage balance of allele genes,
generate new recombination of exons between
different genes, or disrupt regulatory regions,
resulting in variations in gene expression or altered
protein structure and activity. Therefore, if CNVs
are large and affect multiple genes, they are likely
to be involved in different phenotypes, including
disease sensitivity. CNVs can be inherited from a
parent or arise de novo in an individual. Usually, de
novo CNVs are more likely to have damaging effects [1].

Rare CNVs have been linked to an important source
of mutation in many psychopathological traits and
neurodevelopmental disorders, such as intellectual
disability, autism spectrum disorders, attentiondeﬁcit hyperactivity disorder, epilepsy, and schizophrenia [2]. Array comparative genomic hybridization
(aCGH) is a high-resolution technology to detect rare
CNVs on chromosomes that cannot be observed using
conventional cytogenetic karyotyping [2]. Herein, we
report on a 5-year-old Taiwanese girl with a phenotype of psychological developmental delay and mild
macrocephaly with a high broad forehead and identiﬁed a de novo 1.86-Mb microdeletion at 5q35.2-q35.3
associated with Sotos syndrome.

2. Case and methods
The index patient was the ﬁrst child of healthy
non-consanguineous Taiwanese parents and was
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born by cesarean section at 38 weeks of gestational
age following an uneventful pregnancy/delivery,
except for amniotic ﬂuid inhalation. The ages of the
parents at conception were 32 (father) and 27
(mother) years. The birth weight was 3500 g
(50e85th percentile), length of 53 cm (97th percentile), and head circumference was 38 cm (above the
97th percentile). Due to the large head circumference, electroencephalography and brain computerized tomography were performed shortly after birth
and the results were unremarkable.
The parents reported that she started climbing at
the age of 12 months and walked without support at
24 months. When she was 15 months old, she began
receiving physical, language, and functional therapies. She was able to say “mama” and “papa” at 36
months and repeat the words overhead in conversation at the age of 5 years old. However, there has
been no full sentence development yet. At the age of
34 months, the evaluation of psychomotor development according to the Bayley Scales of Infant and
Toddler Development (BSID-III) was performed
and showed that her cognition fell into the range of
slow development (BSIDIII: CCI ¼ 65; 1 percentile),
with a developmental age of approximately 17
months old; language skills fell under the scope of
developmental delay (BSID-III: Lang ¼ 65; 1
percentile), with approximately 14 months of
expression and 13 months of understanding.
The patient started kindergarten at 5 years of age.
She could express her physical needs, such as going
to the toilet and hunger using voice or simple
words. She was easily attracted to things that
interested her, such as mobile phones and e-books.
Due to her lack of language ability, she often
expressed herself as a means of pushing or beating
other people. For the continuation of the psychotherapeutic interview and supportive psychotherapy, she was evaluated using the Adaptive Behavior
Assessment System, Second Edition (ABAS-II) at 65
months of age. Her language and communication
development was 16e26 months old, social and
personality development was 21e40 months old,
and perception and cognitive development were
11e29 months old. All these developmental parameters fell into the scope of developmental delay.
The scores of the General Adaptive Composite were
70 (percentile rank [PR] ¼ 2; 95% CI ¼ 68e72), which
fell within the critical range. The scores for the three
subdomains were: 60 for conceptual (PR ¼ 0.4), 93
for social (PR ¼ 32), and 61 for practical (PR ¼ 0.5).
The patient was brought to the genetic outpatient
clinic of our hospital at the age of 5 years (62
months) for genetic counseling regarding the psychological developmental delay. Her body height,
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weight and body mass index were 112.7 cm (50e85th
percentile), 20.8 kg (85th percentile), and 16.3 kg/m2
(50e85th percentile), respectively, according to the
New Growth Charts for Taiwanese Children and
Adolescents [3]. The Tanner stage was B1P1. On
physical examination, she had a long face with a
broad forehead, sparse eyebrows, mildly depressed
nasal root, large ears, happy and friendly characteristics, above the mean stature, and macrocephaly
(head circumference 57 cm, above the 97th percentile) [Fig. 1A,B,C].
Array-CGH was performed on the patient's DNA
extracted from peripheral blood using SurePrint G3
Human CGH ISCA (Agilent Technologies, Santa
Clara, CA, USA), and data were analyzed using the
Agilent CytoGenomics (v. 4.0.3.12) software.

3. Results and discussion
According to Array-CGH result, we identiﬁed a
1.863 Mb deletion of 5q35.2e35.3 (arr[GRCh37](1-

Fig. 1. Clinical photographs of the patient at the age of 60 months. (A)
Full-body frontal photograph. (B, C) Frontal and side photos of the head
show the long face, sparse hair in the frontoparietal area, sparse eyebrows, hypertelorism, malar hypoplasia, thin philtrum, mild depressed
and broad nasal root, prominent forehead, normal lips, and normal
tongue.
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22,X)x2, 5q35.2q35.3 (175559343_177422760)x1), which
encompasses the NSD1 gene and other 49 genes
and transcripts [Fig. 2, Supplementary Table 1].
This result is compatible with the diagnosis of Sotos
syndrome.
Sotos syndrome (OMIM 117550) is a disease
characterized by overgrowth and intellectual
disability with an incidence of approximately 1 in
15,000 live births [4]. Its inheritance pattern is
autosomal dominant and is caused by a deletion or
mutation in the NSD1 gene, which is mapped to
5q35.2-q35.3 [4,5]. The proportions of intragenic and
microdeletion mutations in Sotos syndrome differ
between countries. In East Asia, studies from Japan
reported that 52% of Japanese patients with Sotos
syndrome were microdeletions, but only 10e15%
were observed in non-Japanese ethnicities [6,7]. In
2005, it was reported that in Hong Kong, Southern
China, only 12% of Sotos syndrome cases were the
microdeletion type, similar to that in a Western
study [8]. In a study in Korea, 53% of Korean patients had 5q35 microdeletion [9]. In Taiwan, Sotos
syndrome was very rare, and only one prenatal
diagnosis case was reported; it was a girl with
5q35.2-q35.3 microdeletion but without follow-up
information [10]. In this study, we describe the case
of a patient with developmental delay who underwent a childhood mental evaluation for several
years and conﬁrmed the diagnosis of Sotos syndrome using molecular cytogenetic methods in the
ﬁnal.
Although Sotos syndrome cases are rare, we
estimated that the microdeletion type of mutation
should be dominant in Taiwanese Sotos syndrome.
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The NSD1 gene encodes the nuclear receptor set
domain protein 1, which is a histone methyltransferase that methylates lysine residues on histone tails [11]. Histones are structural proteins that
bind to DNA, and methylation of histones is often
associated with the transcription regulation of
genes. NSD1 gene mutations disrupt the normal
regulation of genes involved in cell/tissue growth
and development [12].
The deleted region contains 50 genes and transcripts [Supplementary Table 1]; besides NSD1, six
genes, including GPRIN1, SNCB, UNC5A, ZNF346,
RGS14, and DBN1, are also highly associated with
brain function, neural system development, neuron
protecting or a nonprogressive cerebral disorder
with mental retardation [13e20]. The other two
genes, RNF44 and ARL10, are highly expressed in
brain, although their function is unclear [21,22]. In
general, individuals with microdeletion of NSD1
and neighboring genes in the 5q35 region present
with less severe tall stature and more severe intellectual disability, compared to that in individuals
with intragenic mutations [23].
According to the literature reviewed, two cases had
deletion regions very similar to the case that we
described here. One was a 3.5-year-old AfricanAmerican girl, and the other was a 2.5-year-old African boy [24,25]. The clinical features were compared
and summarized in Table 1. All of them had over
growth, either at birth or at the time of reporting. They
had long face, prominent and high forehead, sparse
eyebrow, depressed nasal root, large ears, short
philtrum, pointy chin, and macrocephaly. In neurological and psychiatric symptoms, all of them were

Fig. 2. Array-CGH chromosome 5 showing the deleted segment in chromosome 5q35.2-q35.3 in our patient, size of deletion 1.86 Mb, the deleted genes
were shown within the deleted region.
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Table 1. Summary of clinical characteristics of three cases of microdeletion 5q35.2-q35.3.
Case 1

Case 2

Case 3

This study

Mubungu et al., 2020

Peredo et al., 2013

Ethnicity

Taiwan Han population

Sex
Age (reported)
Deletion region

Female
5-year-old
hg19: 5q35.2-q35.3
175559343-177422760
176132340-177995759

African
Congo
Male
2.5-year-old
hg19: 5q35.2-q35.3
175433847-177430496
176006844-178003495

African American
USA
Female
3.5-year-old
hg18: 5q35.2-q35.3
175409774-177040384
176050165-177680777

1.86 Mb
53 (97th percentile)

2 Mb
53 (85th percentile)

1.631 MB
50.8 (50-75th percentile)

3.5 (50-85th percentile)
38 (>97th percentile)

3.89 (74th percentile)
36.5 (63rd percentile)

3.26 (50th percentile)
38 (>95th percentile)

112.7 (50e85th percentile)

101 (98th percentile)

101.9 (90th percentile)

20.8 (85th percentile)
57 (>97th percentile)

20 (>99th percentile)
53.5 (>99th percentile)

20.6 (>95th percentile)
n/a

Long face with broad forehead,
sparse eyebrows, mild depressed
nasal root, large ears, above the
mean stature, and macrocephaly

Long face, prominent forehead,
sparse eyebrows, malar
hypoplasia and reddish,
depressed nasal root, short
and deep philtrum, thick lip,
macroglossia,
large ears, short ﬁngers, partial
syndactyly of toes
Speech development delay,
moderate impairment of cognitive,
communicative, motor, and
socialemotional performances

Cleft lip and palate,
prominent and high forehead,
hypertelorism, hypoplasia of
the middle face with
depressed nose, prominent
chin

Normal
e

Patent ductus arteriosus
Asthma

Convert to
GRCh38/hg38
Deletion size
Birth
Height (cm)
Weight (kg)
Head
circumference (cm)
Reported
Height (cm)
Weight (kg)
Head
circumference (cm)
Outward
characteristics

Neurological and
psychiatric symptoms

Heart, vascular, and spine
Other clinical symptoms

happy and friendly characteristics,
developmental delay of language
and communication, social and
personality, perception and
cognitive
No ﬁnding
e

Speech delay, mild cerebral
palsy, global developmental
delay

n/a, not available.

development delay in speech and communication,
social and personality, perception and cognitive.
Considering these symptoms and signs, several disease should be suspected, such as Leukodystrophies,
neurocutaneous syndromes (phakomatosis), lysosomal storage disorders and Noonan syndrome. Genetic testing can help clarify the cause of the disease.
The deletion information was converted to the same
database set (GRCh38/hg38).
The deletion region in our case: Chromosome
5:176132340-177995759 (1.86 Mb), AfricanAmerican
girl: Chromosome 5: 176050165-177680777 (1.63 Mb),
African boy: Chromosome 5: 176006844-178003495
(2 Mb). The deletion region of the African boy was the
largest in these three cases; however, the AfricanAmerican girl had more severe dysmorphisms,
including cleft lip palate and patent ductus arteriosus
(PDA), which were not found in the other two cases.
Cleft lip palate was not reported in any Sotos syndrome except in this African-American girl; PDA was

observed in 19% of microdeletion mutation type Sotos
syndrome cases [5]. The number of gene and transcript
deletions in the African boy was 52, 47 in the AfricanAmerican girl, and 50 in our case. Most of these gene
and transcript functions were unknown [Supplementary Table 1]. Although the deletion regions were very
similar, the phenotypes were heterogeneous. More
studies are needed to elucidate the functions and interactions of genes located in this region.
In our patient, some peculiar characteristic facial
appearance was observed, including macrocephaly
since birth, prominent forehead, high anterior
hairline, pointy chin, and subtle down-slanting
palpebral ﬁssures, all of which are compatible with
the diagnosis of Sotos syndrome. Other physical
symptoms that are commonly described in Sotos
syndrome’ cases, such as seizures, scoliosis, cardiac
anomalies, renal anomalies, and joint laxity, were
not observed in this patient at this time, but we will
closely monitor for these at future follow-ups.
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In conclusion, microdeletion or duplication is one
of the most important causes of physical and
mental developmental disorders. Although our
case is generally compatible with typical Sotos
syndrome, after detailed array-CGH analysis and
comparison with other similar deletion cases, we
can extend more data on genotype and phenotype
correlation. In addition, Sotos syndrome is rare
in Taiwan, and it is suggested that genetic analysis
(array-CGH, target gene-NSD1 sequencing)
should be considered early if symptoms of this
case are observed. Genetic diagnostic results
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can provide more information for the patients’
future development and genetic counseling for the
family.
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Supplementary Materials
Supplementary Table-S1.Genes and transcripts list deletion in our case and the other two similar reported cases.
Inheritance Note#

Gene

Location (GRCh38)

Related OMIM disease

AC139491.1
FAM153B
AC139493.1
SIMC1
KIAA1191
AC138956.1
ARL10
NOP16
HIGD2A

5:176049677-176062021
5:176084962-176114798
5:176203313-176203710
5:176238423-176345989
5:176346061-176361764
5:176347940-176353584
5:176365486-176381909
5:176383945-176388762
5:176388750-176389761

e
e
e
n/a
e
e
e
n/a
e

CLTB

5:176392500-176416539 n/a

n/a

AC010297.1 5:176439089-176439238 e
FAF2
5:176448384-176510074 n/a

n/a

RNF44

5:176526711-176537402 n/a

n/a

CDHR2
GPRIN1

5:176542510-176595974 e
5:176595801-176610156 n/a

n/a

SNCB

5:176620081-176630534 Dementia with Lewy body

AD

MIR4281
EIF4E1B
TSPAN17
AC113391.1
LINC01574
UNC5A

5:176629438-176629500
5:176630617-176646595
5:176647483-176659051
5:176707355-176726243
5:176743204-176743871
5:176810518-176880898

e
e
e
e
e
n/a

n/a

HK3
UIMC1
ZNF346

5:176880868-176899346 n/a
5:176905005-177006779 n/a
5:177022695-177067985 n/a

n/a
n/a
n/a

FGFR4

5:177086914-177098144 n/a

n/a

NSD1
RAB24
PRELID1

5:177133772-177300213 Sotos syndrome 1
5:177301197-177303719 n/a
5:177303798-177306949 n/a

AD
n/a
n/a

n/a

n/a

highly expressed in the brain
nucleolar protein
a subunit of the cytochrome c oxidase complex
(complex IV)
encodes one of two clathrin light chain proteins
which are believed to function as regulatory
highly expressed in peripheral blood
of patients with atopic dermatitis
expression in adult and fetal human
brain regions
wide distribution in human brain tissue
and the central nervous system with
highest expression in the spinal cord
Be concentrated in presynaptic nerve
terminals; increased Akt signaling
activity and were resistant to neurotoxic
effects of the pesticide rotenone
micro RNA

long intergenic non-protein coding RNA
developing mouse revealed highest
Unc5a expression in central nervous system
Hexokinases 3
nucleolar protein, cell growth and survival,
protecting neurons
a tyrosine kinase and cell surface receptor
for ﬁbroblast growth factors; involved in
several pathways: cell proliferation,
differentiation, migration, lipid metabolism,
bile acid biosynthesis, vitamin D metabolism,
glucose uptake, and phosphate homeostasis
Ras-associated protein 24
(continued on next page)
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Supplementary Table-S1. (continued )
Inheritance Note#

Gene

Location (GRCh38)

Related OMIM disease

MXD3
LMAN2

5:177307434-177312757 n/a
5:177331566-177351668 n/a

n/a
n/a

AC146507.1 5:177346072-177346426 e
RGS14
5:177357923-177372596 n/a

n/a

5:177384433-177398848 Fanconi renotubular syndrome 2
Hypercalcemia, infantile, 2
Nephrolithiasis/osteoporosis,
hypophosphatemic, 1
5:177400108-177400661 n/a
5:177402140-177409564 Angioedema, hereditary, type III
Factor XII deﬁciency

n/a
AD
AR

GRK6
PRR7
DBN1

5:177426793-177442901 n/a
5:177446813-177456286 n/a
5:177456935-177473637 n/a

n/a
n/a
n/a

PDLIM7
AC145098.1
DOK3
DDX41

5:177483393-177497604
5:177494994-177503647
5:177503783-177510382
5:177511576-177516961

n/a

SLC34A1

PFN3
F12

FAM193B
TMED9
B4GALT7

AC139795.1
AC138819.1
FAM153A
AC140125.1
AC106795.1
PROP1

n/a
e
n/a
Familial myeloproliferative/
lymphoproliferative neoplasms,
adult-onset
5:177519788-177554563 n/a
5:177592202-177597242 e
5:177600131-177610330 Ehlers-Danlos syndrome,
spondylodysplastic type, 1

5:177626435-177672149
5:177682293-177713969
5:177723364-177753206
5:177801203-177803344
5:177809480-177882383
5:177992234-177996242

e
e
e
e
e
Pituitary hormone deﬁciency,
combined, 2

AR
AR
AD

n/a
AD

binds high mannose type glycoproteins and
may facilitate their sorting, trafﬁcking
and quality control
transcripts at high levels in brain, spleen,
and lung
a major part in phosphate homeostasis
a major regulator of Pi homeostasis and is
necessary for normal skeletal development

recurrent skin swelling, abdominal pain
attacks, and episodes of upper airway
obstruction; coagulation cascade
G protein-coupled receptor kinase 6
neurite outgrowth, brain maturation;
Drebrin (125 kD) expression was
signiﬁcantly decreased in the temporal
and frontal cortex of both Down
syndrome and Alzheimer disease
patients, underlie cognitive dysfunction.
These proteins are involved in cytoskeleton

interacted with several spliceosomal proteins,
tumor suppressor gene

n/a
AR

involved in the synthesis of the
glycosaminoglycan-protein linkage
in proteoglycans

AR

a crucial role in the proper development of
somatotrophs, lactotrophs, thyrotrophs, and
gonadotrophs

AD, autosomal dominant; AR, autosomal recessive; n/a, not available; -, no record in OMIM. # https://www.ncbi.nlm.nih.gov/gene/
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